Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05365984
Other study ID # PRO2021-1366
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2022
Est. completion date December 2024

Study information

Verified date April 2022
Source Women's Hospital School Of Medicine Zhejiang University
Contact Jiajun Zhu, doctor
Phone +86-13858089111
Email jiajunzhu@zju.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this prospective multi-center randomized clinical trial, a new follow-up strategy for neonatal jaundice after discharge will be evaluated. It is based on current risk factors of neonatal hyperbilirubinemia, added with the rate of bilirubin production (exhaled carbon monoxide measurement) as a new indicator,and incorporated with Internet Plus technology. Traditional methods following the Chinese guideline for neonatal hyperbilirubinemia were applied in the control group. The morbidity of BIND, the number of outpatient follow-up after discharge and the convenience will be compared between the two groups. The accuracy, effectiveness, safety and convenience of the study strategy will be testified.


Description:

The eligible newborns will be randomized into two groups: the study group (innovative strategy) and the controlled group (traditional strategy). The innovative strategy included the ETCOc measurement in the risk evaluating process and the Internet Plus approach in the follow-up process.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 2500
Est. completion date December 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group N/A to 7 Days
Eligibility Inclusion Criteria: 1. gestational age between 35(+0)~41(+6) 2. birth weight = 2500 g 3. ethics approval obtained 4. parental consent obtained Exclusion Criteria: 1. severe perinatal asphyxia 2. infectious diseases 3. persistent need for respiratory support 4. major congenital malformation 5. inborn errors of metabolism 6. pathological neonatal hyperbilirubinemia due to the defects of red blood cell membrane and erythrocyte enzyme

Study Design


Intervention

Diagnostic Test:
end tidal carbon monoxide corrected for ambient carbon monoxide (ETCOc)
The measurement of end tidal carbon monoxide corrected for ambient carbon monoxide (ETCOc)is conducted in the process of risk evaluation.
Other:
Internet Plus technology
The Internet Plus technology is applied in the process of follow-up management.

Locations

Country Name City State
n/a

Sponsors (6)

Lead Sponsor Collaborator
Women's Hospital School Of Medicine Zhejiang University Jiaxing University Affiliated Women and Children Hospital, Jinhua Central Hospital, Ningbo Women and Children's Hospital, Shaoxing Women's and Children's Hospital, The Children's Hospital of Zhejiang University School of Medicine

References & Publications (12)

American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004 Jul;114(1):297-316. Erratum in: Pediatrics. 2004 Oct;114(4):1138. — View Citation

Bhutani VK, Maisels MJ, Schutzman DL, Castillo Cuadrado ME, Aby JL, Bogen DL, Christensen RD, Watchko JF, Wong RJ, Stevenson DK. Identification of risk for neonatal haemolysis. Acta Paediatr. 2018 Aug;107(8):1350-1356. doi: 10.1111/apa.14316. Epub 2018 Apr 16. — View Citation

Bhutani VK, Wong RJ, Stevenson DK. Hyperbilirubinemia in Preterm Neonates. Clin Perinatol. 2016 Jun;43(2):215-32. doi: 10.1016/j.clp.2016.01.001. Epub 2016 Mar 23. Review. — View Citation

Castillo A, Grogan TR, Wegrzyn GH, Ly KV, Walker VP, Calkins KL. Umbilical cord blood bilirubins, gestational age, and maternal race predict neonatal hyperbilirubinemia. PLoS One. 2018 Jun 1;13(6):e0197888. doi: 10.1371/journal.pone.0197888. eCollection 2018. — View Citation

Cortey A, Renesme L, Raignoux J, Bedu A, Casper C, Tourneux P, Truffert P. [Management of jaundice in the newborn=35 GW: From screening to follow-up after discharge. Guidelines for clinical practice]. Arch Pediatr. 2017 Feb;24(2):192-203. doi: 10.1016/j.arcped.2016.11.011. Epub 2017 Jan 14. French. — View Citation

Dalal SS, Mishra S, Agarwal R, Deorari AK, Paul V. Does measuring the changes in TcB value offer better prediction of Hyperbilirubinemia in healthy neonates? Pediatrics. 2009 Nov;124(5):e851-7. doi: 10.1542/peds.2008-3623. Epub 2009 Oct 12. — View Citation

Du L. [Prevention and intervention strategies for hyperbilirubinemia induced brain injury]. Zhonghua Er Ke Za Zhi. 2014 Oct;52(10):721-3. Chinese. — View Citation

Ma X, Zhu J, Du L. Neonatal Management During the Coronavirus Disease (COVID-19) Outbreak: The Chinese Experience. Neoreviews. 2020 May;21(5):e293-e297. doi: 10.1542/neo.21-5-e293. — View Citation

Ma XL, Chen Z, Zhu JJ, Shen XX, Wu MY, Shi LP, Du LZ, Fu JF, Shu Q. Management strategies of neonatal jaundice during the coronavirus disease 2019 outbreak. World J Pediatr. 2020 Jun;16(3):247-250. doi: 10.1007/s12519-020-00347-3. Epub 2020 Feb 28. — View Citation

Rong ZH, Luo F, Ma LY, Chen L, Wu L, Liu W, Du LZ, Luo XP. [Evaluation of an automatic image-based screening technique for neonatal hyperbilirubinemia]. Zhonghua Er Ke Za Zhi. 2016 Aug;54(8):597-600. doi: 10.3760/cma.j.issn.0578-1310.2016.08.008. Chinese. — View Citation

Subspecialty Group of Neonatology, The Society of Pediatrics, Chinese Medical Association. [The experts consensus on the management of neonatal hyperbilirubinemia]. Zhonghua Er Ke Za Zhi. 2014 Oct;52(10):745-8. Chinese. — View Citation

Tabatabaee RS, Golmohammadi H, Ahmadi SH. Easy Diagnosis of Jaundice: A Smartphone-Based Nanosensor Bioplatform Using Photoluminescent Bacterial Nanopaper for Point-of-Care Diagnosis of Hyperbilirubinemia. ACS Sens. 2019 Apr 26;4(4):1063-1071. doi: 10.1021/acssensors.9b00275. Epub 2019 Mar 29. — View Citation

* Note: There are 12 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary the incidence of acute bilirubin encephalitis the number of infants with acute bilirubin encephalitis in each group within 2 week after birth
Primary the bilirubin level of readministration for hyperbilirubinemia the average bilirubin level of infants, who are readmitted for hyperbilirubinemia within 1 months
Secondary the cost for the issue of jaundice follow-up compare the fee for intelligent follow-up with the fee for clinical visiting according to present jaundice follow-up suggestion within 1 month
Secondary the time for the issue of jaundice follow-up compare the time for intelligent follow-up,including the time for TSB measurement and internet commuication,with the time for clinical visiting according to present jaundice follow-up suggestion within 1 month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04868019 - Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control Trial N/A
Completed NCT00114543 - Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight Phase 3
Completed NCT02000830 - Follow up Study of Patients Having Participated in Clinical Trial 64,185-204
Completed NCT01887327 - Stannsoporfin With Light Therapy for Newborn Babies With Jaundice Phase 2
Completed NCT05356273 - The Effect of Massage on the Bilirubin Level in Term Infants Receiving Phototherapy N/A
Suspended NCT03741803 - Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice N/A
Recruiting NCT03876678 - The Efficacy of Oral Probiotics on Neonatal Hyperbilirubinemia N/A
Recruiting NCT04251286 - Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network
Completed NCT03723005 - A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns
Recruiting NCT06087874 - Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice Phase 2
Completed NCT03624335 - Influence of Umbilical Cord Clamping Time in the Newborn N/A
Recruiting NCT06324799 - The Effect of Position Change Frequency on Hyperbilirubinemia N/A
Recruiting NCT06209489 - White Cover and Massage Impact on Bilirubin Levels and Phototherapy Duration in Newborns N/A
Completed NCT03824990 - Multi-center Clinical Study on Neonatal Hyperbilirubinemia N/A
Withdrawn NCT01330667 - Effect of Early Limited Formula on Total Serum Bilirubin Among Newborns With Hyperbilirubinemia N/A
Completed NCT01169740 - Transcutaneous Measurement of Jaundice in the Newborn N/A
Recruiting NCT06238349 - Hyperbilirubinemia in Full-term Neonates Phase 4
Completed NCT03007563 - Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice N/A
Completed NCT01763632 - Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants N/A
Completed NCT01762189 - The Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants N/A